Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Tel Hashomer Medical Research Infrastructure And Services Ltd
Tel Hashomer Medical Research Infrastructure And Services Ltd The Chaim Sheba Medical Center

Tel Hashomer Medical Research Infrastructure And Services Ltd patents


Recent patent applications related to Tel Hashomer Medical Research Infrastructure And Services Ltd. Tel Hashomer Medical Research Infrastructure And Services Ltd is listed as an Agent/Assignee. Note: Tel Hashomer Medical Research Infrastructure And Services Ltd may have other listings under different names/spellings. We're not affiliated with Tel Hashomer Medical Research Infrastructure And Services Ltd, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "T" | Tel Hashomer Medical Research Infrastructure And Services Ltd-related inventors


Isolated populations of renal stem cells and methods of isolating and using same

Isolated populations of fetal renal stem cells and progenitor cells are provided. Also provided are methods of generating and using these isolated populations of cells.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Chest radiograph (cxr) image analysis

A method for estimating a presence of a pneumothorax abnormality. The method comprises classifying at least one texture feature of each of a plurality of pixels of a chest radiograph (CXR) image to generate an output map, identifying at least one lung contour in said CXR image, identifying a plurality... Tel Hashomer Medical Research Infrastructure And Services Ltd

Anti ceacam1 antibodies and methods of using same

A hybridoma cell which has been deposited under ATCC Accession Number PTA-9974 is disclosed. Also provided are Antibodies and methods of using same.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Peptides and compositions for prevention of cell adhesion and methods of using same

Compositions comprising an isolated peptide, which may for example optionally comprise a sequence selected from the group consisting of YDYNWY (SEQ ID NO: 1), YDYNLY (SEQ ID NO: 2), FDYNFY (SEQ ID NO: 3), FDYNLY (SEQ ID NO: 4), FDYNWY (SEQ ID NO: 5), YDWNLY (SEQ ID NO: 6), YDWHLY... Tel Hashomer Medical Research Infrastructure And Services Ltd

Prostaglandin transporter inhibitors for inhibiting ovulation

The present invention provides methods and compositions for inhibiting ovulation in a female subject, including a subject in need of contraceptives and a subject undergoing fertility treatments. The methods comprise administering to the female subject at least one prostaglandin transporter (PGT) inhibitor.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Methods of predicting clinical course and treating multiple sclerosis

Provided are methods and kits for classifying a subject as being more likely to have benign multiple sclerosis (BMS) or as being more likely to have typical relapsing remitting multiple sclerosis (RRMS). Classification of multiple sclerosis disease course is performed by comparing a level of expression of at least one... Tel Hashomer Medical Research Infrastructure And Services Ltd

Preventing and treating inflammatory skin diseases

The present invention relates to methods of treating, preventing, reducing the severity of, reducing the incidence of, delaying the onset of, or reducing pathogenesis of an inflammatory skin disease, condition or lesion in a human subject, which include the step of administering to the subject a therapeutically effective amount of... Tel Hashomer Medical Research Infrastructure And Services Ltd

Methods for expanding t cell populations

The present invention provides methods for expanding populations of T cell. The present invention further provides pharmaceutical compositions comprising the expanded T cells, including, γδ T cells, and use thereof for treating infectious, autoimmune or malignant diseases.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Synthetic somatostatin receptor ligands

Disclosed are Somatostatin receptor ligands comprising a peptide moiety, pharmaceutical compositions and uses thereof. Disclosed are also synthetic Somatostatin receptor ligands comprising a cyclic peptide moiety and an active agent moiety covalently bonded to the cyclic peptide moiety through a nitrogen atom of a side chain functional group of an... Tel Hashomer Medical Research Infrastructure And Services Ltd

Rna polymerase i inhibitors and uses thereof

Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Rna polymerase i inhibitors and uses thereof

Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Targeted liposomes encapsulating iron complexes and their uses

Provided are liposomes including a lipid membrane enclosing an intraliposomal compartment. The liposomes may encapsulate an iron complex, including an iron moiety and a macromolecule, in the intraliposomal compartment. The liposomes may additionally have a targeting moiety associated with the liposomal membranes. The targeting moiety may be exposed at the... Tel Hashomer Medical Research Infrastructure And Services Ltd

Blood-brain barrier disrupting agents and uses thereof

The present invention relates to blood-brain barrier disrupting agents containing a modified serum albumin comprising serum albumin. The present invention further relates to pharmaceutical compositions comprising said agents and use thereof for the treatment of brain diseases and disorders.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Methods for preventing premature follicle activation

Provided are compositions and methods for preventing premature follicle activation and loss induced by acute insults, such as, medical treatment, a disease or a disorder, thereby preserving fertility in a subject.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Methods for preventing transplantation-induced follicle activation

Provided are compositions and methods for preventing premature follicle activation and loss induced by transplantation of ovaries or tissues derived from ovaries, thereby preserving fertility in a subject.... Tel Hashomer Medical Research Infrastructure And Services Ltd

System and objective chromatic perimetry analysis using pupillometer

The present invention relates to a system, device and a method for objective visual field testing and in particular, to such a system and method in which provides objective chromatic perimetry test or color vision test using a pupillometer.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Identification of cancer stem cells markers and use of same for diagnosis and treatment

wherein an increase in the amount of the antigen in the first population of tumor cells as compared to the amount of the antigen in the second population of tumor cells is indicative of a cancer stem cell marker in the human primary tumor.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Medical device for tissue removal

The present disclosure provides medical devices for creating a channel in a biological soft tissue. The devices comprise an integral rotatable tool formed by an elongated distal member and a proximal shaft, the elongated member having a distal end portion and a proximal end portion, the distal end portion comprising... Tel Hashomer Medical Research Infrastructure And Services Ltd

Toroidal glaucoma drainage device

The invention provides an intraocular drainage implant whose drainage capacity is regulated by opening a plurality of laser-sensitive spots. The implant is useful for fine regulation of the eye fluid outflow in handling glaucoma.... Tel Hashomer Medical Research Infrastructure And Services Ltd

Par-1 based therapeutic conjugates and uses thereof

The present invention is directed to a peptide conjugate comprising an alpha-amino protecting moiety, a peptide comprising the amino acid sequence at least 3 amino-acid long derived from the C′-terminus of PAR-1, or an active variant thereof and a protease-disabling moiety. The present invention is further directed to pharmaceutical compositions... Tel Hashomer Medical Research Infrastructure And Services Ltd

High resolution intraoperative mri images

A method of providing an intraoperative magnetic resonance image of a target site of a patient body at which a medical procedure is performed, the method comprising: acquiring a high resolution preoperative magnetic resonance image (MRI), MRI0, of a first region of the patient comprising the target site, the MRI0... Tel Hashomer Medical Research Infrastructure And Services Ltd








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Tel Hashomer Medical Research Infrastructure And Services Ltd in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Tel Hashomer Medical Research Infrastructure And Services Ltd with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###